Anabolic Agents to Treat Osteoporosis in Older People: Is There Still Place for Fluoride?
- 1 October 2001
- journal article
- review article
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 49 (10) , 1387-1389
- https://doi.org/10.1046/j.1532-5415.2001.49271.x
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Fluoride for treating postmenopausal osteoporosisCochrane Database of Systematic Reviews, 2000
- Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of OsteoporosisEndocrine Reviews, 2000
- Advances in the osteoblast lineageBiochemistry and Cell Biology, 1998
- Role of cytokines in bone resorptionBone, 1995
- New insights into the cellular, biochemical, and molecular basis of postmenopausal and senile osteoporosis: Roles of IL-6 and gp130International Journal of Immunopharmacology, 1995
- Fluoride therapy in postmenopausal osteopenic women: Effect on vertebral and femoral bone density and prediction of bone responseOsteoporosis International, 1991
- The effect of sodium fluoride on trabecular architectureBone, 1991
- Journal of Bone and Mineral ResearchJournal of Bone and Mineral Research, 1990
- The Essential Trace ElementsScience, 1981
- Effect of Sodium Fluoride on Calcium Metabolism of Human BeingsNature, 1961